Richard C. Pasternak

All filings by Richard C. Pasternak on record concern Milestone Pharmaceuticals Inc. Over a trading history stretching from 11 November 2019 to 20 October 2022, the count stands at 10 filings.

Purchases make up the whole of the open-market record (9 purchases, €39k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2022: 9 purchases and no sales on the market.

Half of the purchases are above €1,393 and half below. Across 9 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 21 October 2022 with a transaction in Milestone Pharmaceuticals Inc. The most recent open-market purchase was published on 21 October 2022, 1,480 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.